
("FGEN" or the "Company")
Total Voting Rights
Following the transactions in
627,660,892 shares (excluding treasury shares)
33,870,337 shares held in treasury
661,531,229 shares (including treasury shares)
The Company has 627,660,892 ordinary shares with voting rights in issue. The above figure (627,660,892) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
For further information, please contact:
Foresight Group
|
+44(0)20 3667 8100 |
|
+44(0)20 3100 0000
|
SEC Newgate
|
+44 (0)20 3757 6882 |
Apex Fund and
|
+44(0)20 3530 3600 |
About FGEN
FGEN's invests into environmental infrastructure to deliver stable returns, long term predictable income and opportunities for growth, whilst driving decarbonisation and sustainability.
Investing across renewable generation, other energy infrastructure and sustainable resource management, it targets projects and businesses with an emphasis on long term stable cash flows, secured revenues, inflation linkage and the delivery of essential services. FGEN's aim is to provide investors with a sustainable, progressive dividend per share, paid quarterly, alongside the potential for capital growth.
The target dividend for the year to
FGEN is an Article 9 fund under the EU Sustainable Finance Disclosure Regulation and has a transparent and award-winning approach to ESG.
Further details can be found on FGEN's website www.fgen.com and LinkedIn page.
LEI: 213800JWJN54TFBMBI68
(1) These are targets only and not profit forecasts. There can be no assurance that these targets will be met or that the Company will make any distributions at all.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the